Diabetes, Vol 29, Issue 12 979-990, Copyright © 1980 by American Diabetes Association

ARTICLES

Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog

G Toffolo, RN Bergman, DT Finegood, CR Bowden and C Cobelli

We propose an approach to quantifying the sensitivity of B cells to glucose in the intact organism, whereby we interpret the complex dynamic plasma insulin response to glucose injection in terms of a minimal mathematical model of posthepatic insulin delivery and insulin clearance. The best model for this purpose was chosen by comparing the ability of a series of proposed models to account precisely for plasma insulin dynamics. Intravenous glucose tolerance tests (IVGTT) (300 mg/kg) were performed on conscious dogs, and blood was sampled frequently until the basal steady state was reestablished. Glucose injection produced variable plasma insulin responses, which were characterized by an early peak (76 microU/ml above basal), a plateau with occasional additional peaks, and by an abrupt return of plasma insulin to basal by 37 min. A set of eight models was examined; one emerged as superior, in that it was able to account for insulin dynamics with the smallest number of physiologically meaningful parameters (N = 4). The chosen (minimal) model assumes that (1) clearance of insulin is of the first order, (2) the initial peak represents a bolus of insulin loaded into the plasma after the glucose injection, and (3) the rate of the secondary rise in insulin is determined by the concentration of glucose in plasma above a specific threshold value. The sensitivity of first phase insulin delivery to glucose (phi 1; 1.28 +/- 0.15 microU/ml per min per mg/dl), the sensitivity of the secondary phase to glucose concentration [phi 2; 0.038 +/- 0.005 (microU/mg) . min-2], and the threshold for glucose stimulation of second phase secretion (h; 125 +/- 8 mg/100 ml) were all precisely estimated from the dynamic insulin responses. These three parameters of insulin kinetics (phi 1, phi 2, and h) can be calculated from a single IVGTT, and they characterize the insulin responsiveness of a single individual. Estimating these characteristic parameters of insulin kinetics from IVGTT data has potential for quantitating the individual factors contributing to glucose-stimulated insulin secretion in intact animal models, and it may be applicable to man.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. E. Silber, P. M. Jauslin, N. Frey, R. Gieschke, U. S. H. Simonsson, and M. O. Karlsson An Integrated Model for Glucose and Insulin Regulation in Healthy Volunteers and Type 2 Diabetic Patients Following Intravenous Glucose Provocations J. Clin. Pharmacol., September 1, 2007; 47(9): 1159 - 1171. [Abstract] [Full Text] [PDF]

				S. Del Prato, R. Miccoli, and G. Penno Review: The importance of effective early phase insulin secretion The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 198 - 202. [Abstract] [PDF]

				R. Weiss, S. Caprio, M. Trombetta, S. E. Taksali, W. V. Tamborlane, and R. Bonadonna {beta}-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth Diabetes, June 1, 2005; 54(6): 1735 - 1743. [Abstract] [Full Text] [PDF]

				I. F. Godsland, D. Crook, A. J. Proudler, and J. C. Stevenson Hemostatic Risk Factors and Insulin Sensitivity, Regional Body Fat Distribution, and the Metabolic Syndrome J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 190 - 197. [Abstract] [Full Text] [PDF]

				D. E. Mager, D. R. Abernethy, J. M. Egan, and D. Elahi Exendin-4 Pharmacodynamics: Insights from the Hyperglycemic Clamp Technique J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 830 - 835. [Abstract] [Full Text] [PDF]

				A. Caumo and L. Luzi First-phase insulin secretion: does it exist in real life? Considerations on shape and function Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385. [Abstract] [Full Text] [PDF]

				C. W. Yeckel, R. Weiss, J. Dziura, S. E. Taksali, S. Dufour, T. S. Burgert, W. V. Tamborlane, and S. Caprio Validation of Insulin Sensitivity Indices from Oral Glucose Tolerance Test Parameters in Obese Children and Adolescents J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1096 - 1101. [Abstract] [Full Text] [PDF]

				I. F. Godsland, J. R. Rosankiewicz, A. J. Proudler, and D. G. Johnston Plasma Total Homocysteine Concentrations Are Unrelated to Insulin Sensitivity and Components of the Metabolic Syndrome in Healthy Men J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 719 - 723. [Abstract] [Full Text]

				A. D. Gaetano, G. Mingrone, M. Castagneto, and M. Calvani Carnitine Increases Glucose Disposal in Humans J. Am. Coll. Nutr., August 1, 1999; 18(4): 289 - 295. [Abstract] [Full Text] [PDF]

				R.N. Bergman, C. Cobellit, and G. Toffolo Minimal models of glucose/insulin dynamics in the intact organism: A novel approach for evaluation of factors controlling glucose tolerance Transactions of the Institute of Measurement and Control, October 1, 1981; 3(4): 207 - 216. [Abstract] [PDF]